Royal Biologics
PrivateLast Round
Early Funding
Jun 19, 2019
Company Overview
Royal Biologics operates in Healthcare & Life Sciences and is based in Hackensack, New Jersey. Its latest recorded funding round was an Early Funding round in June 2019.
Royal Biologics is a medical devices company that manufactures and distributes orthobiologics, stem cell therapy devices, and spinal implant hardware.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Royal Biologics Comparables
Compare Royal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRP Concepts | 86% | |
| Isto Biologics | 81% | |
| T-Lab | 81% |
For institutional investors. Book with your work email.
Royal Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Royal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Creek Capital Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 479% MoM, reaching 4K.
- May 4, 2025
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Royal Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Royal Biologics's valuation, stock price, and market status.
Is Royal Biologics a public or private company?
Royal Biologics is a private company.
What is the current stock price of Royal Biologics?
Royal Biologics is a private company, so its shares have no public market price. Caplight tracks Royal Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Royal Biologics worth (valuation)?
Valuation information for Royal Biologics is not publicly available.
Can I buy Royal Biologics stock?
Royal Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Royal Biologics's last funding round?
Royal Biologics's most recent funding round was Early Funding on June 19, 2019.
Who are the main investors in Royal Biologics?
Key investors in Royal Biologics include Granite Creek Capital Partners.
Will Royal Biologics IPO soon?
No public IPO plans have been announced for Royal Biologics.
How can I track Royal Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Royal Biologics's shares on secondary markets.